Poland· PL-100529775
Winlevi
A clascoterone product containing clascoteronum, registered in Poland by Cassiopea S.p.A.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Clascoterone is registered in 12 of 19 countries.
Countries holding a registration under ATC D10AX06 (clascoterone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Clascoterone · ATC D10AX06
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Clascoteronum
- Manufacturer
- Cassiopea S.p.A.
- Country
- Poland (PL)
- ATC code
- D10AX06
- ATC class
- Clascoterone
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin08059529660020
- gtin8059529660105
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Clascoterone in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaWINLEVICassiopea S.p.A., Lainate
- SpainWINLEVI 10 MG/G CREMACassiopea S.P.A.
- FinlandWinleviCassiopea S.p.A.
- IrelandWinlevi 10 mg/g creamCassiopea S.p.A.
- IcelandWinleviCassiopea S.p.A.
- NetherlandsWinlevi 10 mg/g creamCassiopea S.p.A.
- NorwayWinleviCassiopea S.p.A
- SwedenWinlevi 10 mg/g KrämCassiopea S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Winlevi
- Iceland · Winlevi
- Liechtenstein · Winlevi
- Norway · Winlevi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a072fb03-fede-42a6-86e2-dd93a9d681be GET /v1/drugs/a072fb03-fede-42a6-86e2-dd93a9d681be?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem",
"source": "urpl",
"strength": "10 mg/g",
"packaging": "Rpz ¦ EU/1/25/1927/001 ¦ 164980\n1 tuba 10 g\n08059529660020 ¦ Rpz ¦ EU/1/25/1927/002 ¦ 164981\n1 tuba 30 g\n8059529660105 ¦ Rpz ¦ EU/1/25/1927/003 ¦ 164982\n1 tuba 60 g",
"substance": "Clascoteronum 10 mg/g",
"common_name": "Clascoteronum",
"pl_product_id": "100529775",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about clascoterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.